Advances in stem cell biology over the past decade have fueled interestin new therapies for acute and chronic cardiovascular diseases.Pre-clinical work with a variety of cell types has suggested efficacyin improving ischemia and ventricular function, although mechanisms ofeffect remain to be fully explained. Human studies using certain cell typeshave shown modest clinical efficacy, while the safety of these experimentaltherapies supports continuing patient-oriented research.
Key words: stemcells, cardiovascular diseases
|
